Apple Inc. (AAPL), BioDelivery Sciences International Inc. (BDSI) Among Thomas Bailard’s Top Q2 Top Picks

Thomas Bailard is the co-founder and current manager of Bailard Inc. Located in California, Bailard uses quantitative and fundamental analyses to choose its investments. In its latest 13F filing, Bailard Inc. has disclosed a total of 235 positions as of the end of the second quarter of 2014. The value of the fund’s equity portfolio amounted to $650.1 million, up from $630.5 million reported as at the end of the previous quarter.

AAPL Apple Store

From the Bailard’s equity portfolio, we have picked top five holdings, in term of value. The first on the list is Apple Inc. (NASDAQ:AAPL), in which the fund boosted its position to 84,196 shares, worth $7.82 million, from 9,142 shares. For its fiscal 2014 third quarter ended June 28, 2014, Apple Inc. (NASDAQ:AAPL) reported revenue of $37.4 billion, compared to $35.3 billion in the year-ago quarter. Its quarterly net profit was $7.7 billion, or $1.28 per diluted share, compared to net profit of $6.9 billion, or $1.07 per diluted share, in the same quarter of 2013. Among other shareholders of Apple Inc. (NASDAQ:AAPL) include David Einhorn‘s Greenlight Capital and Natixis Global Asset Management‘s Harris Associates, holding 1.99 million shares and 1.56 million shares, respectively.

Bailard revealed upping its stake in BioDelivery Sciences International Inc. (NASDAQ:BDSI) to 398,000 shares, with a reported value of $4.80 million. Previously, the fund reported ownership of 342,400 shares of the company. BioDelivery Sciences International Inc. (NASDAQ:BDSI) is a specialty pharmaceutical company focusing in the areas of pain management and addiction medicine, has a market cap of $622.01 million. Aside from Bailard, Deerfield Management, led by James E. Flynn, owns 3.99 million shares of BioDelivery Sciences International Inc. (NASDAQ:BDSI) and Kevin Kotler’s Broadfin Capital holds 3.47 million shares.

The third position is held by Johnson & Johnson (NYSE:JNJ), in which the fund disclosed a $4.36 million stake, which contains 41,638 shares. The stake represents an increase from 39,373 the fund held previously. Recently, Johnson & Johnson (NYSE:JNJ), which is engaged in the research and development and sale of health care products, announced that its board of directors approved the repurchase of up to $5 billion of the company’s common stock. Other significant shareholders of Johnson & Johnson (NYSE:JNJ) include Ken Fisher’s Fisher Asset Management, owning 9.98 million shares, and Donald Yacktman’s Yacktman Asset Management, holding 9.57 million shares of the company.

In Chevron Corporation (NYSE:CVX), Bailard disclosed holding 30,575 shares, with a reported value of $3.99 million. The stake is up from 29,138 the fund held earlier. Chevron Corporation (NYSE:CVX) is an integrated energy company having a market cap of $248.60 billion. Last month, the company’s subsidiary Chevron Global Energy Inc. announced the sale of its 25% non-operated interest in a producing oil concession in southern Chad and the related export pipeline interests to the Republic of Chad for about $1.3 billion. In addition to Bailard, other shareholders of the company include Ken Fisher’s Fisher Asset Management, owning 3.50 million shares, according to our record. Another investor, Adage Capital Management, managed by Phill Gross and Robert Atchinson, revealed owning 2.73 million shares of Chevron Corporation (NYSE:CVX).

On the fifth spot is Enanta Pharmaceuticals Inc. (NASDAQ:ENTA), in which the fund increased its position to 91,500 shares, worth $3.94 million, from 74,306 shares. Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) is a research and development-focused biotechnology company. For the fiscal second quarter ended March 31, 2014, the company reported revenue of $2.2 million, compared to $1.2 million for the same period of 2013. It reported a net loss of $5.2 million, compared to a net loss of $3.7 million for the same quarter last year. The shareholders of the company, in addition to Bailard, include Peter Kolchinsky’s RA Capital Management and Mitchell Blutt’s Consonance Capital Management, holding 1.54 million and 1.25 million shares of the company, respectively.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The Top 10 Most Expensive Digital Cameras to Snap Stunning Shots With

The 10 Highest Quality Fast Food Restaurants In America Today

The 8 Best Halloween Decorating Ideas to Spook Up Your House

10 Marvel Women that Should Get a Movie Right Now

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

The 10 Most Expensive Clothing Stores in the United States to Get Decked Out At

The 5 Biggest Kickstarter Scams That Swindled Backers’ Donations

The 10 Most Expensive Boarding Schools In the World

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

Top 6 Cities For The Ultra Rich to Live in Comfort

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!